SGVector vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/sgvector/ubrigene

Category	SGVector	uBriGene
Listed site	cro	both
Summary	SGVector develops and manufactures viral vectors for cell and gene therapies, offering vector design, process development, scale-up, and analytical testing services with a scalable suspension-based platform.	uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Services	Translational Research Analytical Method Development & Validation	Analytical Method Development & Validation US FDA Regulatory Strategy EU EMA Regulatory Strategy China NMPA Regulatory Strategy Translational Research
Modalities	Cell Therapy Gene Therapy AAV / Viral Vector Platform	mRNA Cell Therapy Gene Therapy AAV / Viral Vector Platform
Indications	Data not yet provided.	Oncology
Locations	Headquarters, Singapore, Singapore, Singapore	Headquarters, Maryland, Maryland, USA Boston, Boston, Massachusetts, USA Worcester, Worcester, Massachusetts, USA
Certifications	Data not yet provided.	FDA · Identifier: 20+ INDs filed and accepted EMA · Identifier: 20+ INDs filed and accepted NMPA · Identifier: 20+ INDs filed and accepted
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.